Anti-Vasopermeability Effects of PEDF in Retinal-Renal Disorders

Publisher： Bentham Science Publishers

E-ISSN： 1875-5666|10|3|279-283

ISSN： 1566-5240

Source： Current Molecular Medicine, Vol.10, Iss.3, 2010-01, pp. : 279-283

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Transplantation issues in pediatric retinal-renal syndromes

By Acott P.D.   McLellan D.H.   Wade A.W.   McDonald A.T.J.   Crocker J.F.S.  

Transplantation Proceedings, Vol. 30, Iss. 5, 1998-08 ,pp. : 1997-1999

Elsevier

Access to resources Recommend Favorite

Anti-Atherothrombogenic Properties of PEDF

By  

Current Molecular Medicine, Vol. 10, Iss. 3, 2010-04 ,pp. : 284-291

Bentham Science Publishers

Access to resources Recommend Favorite

The Neuroprotective Role of PEDF: Implication for the Therapy of Neurological Disorders

By  

Current Molecular Medicine, Vol. 10, Iss. 3, 2010-04 ,pp. : 259-266

Bentham Science Publishers

Access to resources Recommend Favorite

PEDF: anti-angiogenic guardian of ocular function

By Bouck N.  

Trends in Molecular Medicine, Vol. 8, Iss. 7, 2002-07 ,pp. : 330-334

Elsevier

Access to resources Recommend Favorite

Retinal Vasculitis Associated with the Anti-Synthetase Syndrome

By Tarabishy Ahmad B.   Khan Mariam   Bunyard Matthew   Lowder Careen Y.  

Ocular Immunology and Inflammation, Vol. 18, Iss. 1, 2010-01 ,pp. : 16-18

Informa Healthcare

Access to resources Recommend Favorite